Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | TLR8 | Q9NR97 | 6/20 | 0.49 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3391214 | 1.00 | MAPT (0.50) | MAPTTLR8LIPGKDM4EALDH1A1 | |
| SCHEMBL10899167 | 1.00 | MAPT (0.50) | MAPTTLR8LIPGKDM4EALDH1A1 | |
| SCHEMBL6235138 | 1.00 | MAPT (0.50) | MAPTTLR8LIPGKDM4EALDH1A1 | |
| SCHEMBL11144398 | 1.00 | MAPT (0.50) | MAPTTLR8LIPGKDM4EALDH1A1 | |
| SCHEMBL11587314 | 1.00 | MAPT (0.50) | MAPTTLR8LIPGKDM4EALDH1A1 | |
| SCHEMBL7532153 | 0.98 | TLR8 (0.50) | MAPTTLR8LIPGKDM4EALDH1A1 | |
| SCHEMBL11590172 | 0.93 | TLR8 (0.49) | MAPTTLR8KDM4EHSD17B10CYP3A4 | |
| Sulfuric Acid SCHEMBL29070868 | 0.90 | MAPT (0.46) | MAPTTLR8LIPGKDM4EALDH1A1 | |
| SCHEMBL29208055 | 0.90 | MAPT (0.50) | MAPTTLR8LIPGKDM4EALDH1A1 | |
| SCHEMBL27513778 | 0.90 | MAPT (0.50) | MAPTTLR8LIPGKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2203519-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | King Industries (US) | 2010-07-07 | — | — | EP | claimed |
| US-20090104363-A1 | Sulfonate esters as latent acid catalysts | KING INDUSTRIES | 2009-04-23 | — | — | US | claimed |
| WO-2009045466-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | KING INDUSTRIES (US) | 2009-04-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090104363-A1 | Sulfonate esters as latent acid catalysts | ORAI1, SARAF, NAPA | MAPT 688/4885TLR8 3066/4885LIPG 991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.